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Abstract
Objectives:  To determine Y-chromosome microdeletion of azoospermia factor (AZF) loci and the concomi-
tant testicular pathology in azoospermic and severely oligozoospermic infertile men.
Patients and  methods:  DNA from blood and semen of 50 azoospermic and severely oligozoospermic infer-
tile men (study group) and 54 healthy fertile men (control group) was investigated for microdeletion in AZF
loci, using several Sequence-Tagged Site (STS) markers for AZF. Additionally, testicular biopsies from
infertile men were examined to evaluate testicular morphological changes.
Results:  22% (11/50) of the patients of the study group had at least one microdeletion in one or more loci
of the AZF sub-regions. Sixteen microdeletions were found in the DNA extracted from blood, while 19
microdeletions were found in the DNA extracted from semen. Microdeletions were detected in the 3 AZFb
loci in one case, in both AZFb and AZFc loci in another and in two AZFc loci in a third case; 8 cases had
sporadic microdeletions in a single locus. Moreover, the incidence of both AZFb and AZFc microdeletions
was 14% (DNA from blood) and 16% (DNA from semen), whereas AZFa microdeletions were found in
only 2% (DNA from blood) and 4% (DNA from semen) of the patients. The testicular biopsies revealed
variable histological changes ranging from hyalinized seminiferous tubules to arrested spermatogenesis.
No microdeletion was detected in the control subjects.
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Conclusion:  Y-chromosome microdeletions of the AZF loci are frequently seen in azoospermic and severely
oligozoospermic infertile men and are usually associated with impaired spermatogenesis and variable
degrees of testicular histological changes.
© 2015 Pan African Urological Surgeons’ Association. Production and hosting by Elsevier B.V. All rights reserved.
Introduction
Infertility is a major health problem affecting approximately 15% of
all couples seeking to conceive a child. The male factor is assumed
to be responsible for infertility in approximately 40–50% of the
cases, and both qualitative and quantitative abnormalities in sperm
production are present in 40% of infertile men [1,2]. A number
of known risk factors such as genital infection, anatomical abnor-
malities, varicocele, immunological factors, genetic aberrations and
others are linked to male infertility [3]. However, in a significant
number of cases the causes of male infertility remain unknown;
a distinction is made between idiopathic infertility with a marked
reduction in semen quality and unexplained infertility with normal
semen parameters [3,4].
Y-chromosome microdeletions constitute the second most common
genetic cause of male infertility. The distal end of the long arm of the
Y chromosome includes the azoospermia factor (AZF) locus which
contains the gene(s) necessary for spermatogenesis. The AZF locus
has been mapped to a region in band q11.23 of the Y chromosome
[5,6]. The AZF region is divided into three sub-regions designated
as AZFa, AZFb and AZFc. Spontaneous mutation or loss of one
of these loci in the paternal germ line leads to severely disturbed
spermatogenesis [7–9]. Also, these regions may be associated with
a particular testicular histology.
The association between Y-chromosome microdeletion and defec-
tive spermatogenesis has been studied previously, and the frequency
of Y-chromosome microdeletions has been reported to account for
5–10% in azoospermic and 2–5% in severely oligozoospermic men
[5,10].
As the frequency of Y-chromosome microdeletions may vary among
different ethnical populations, we conducted this study to evaluate
azoospermic/severely oligozoospermic infertile men in our local
community. Several Sequence-Tagged Site (STS) marker sequences
on the long arm of the Y chromosome (AZF sub-regions) were
investigated. Furthermore, testicular biopsies were processed for
histological examination to evaluate possible morphological abnor-
malities.
Patients  and  methods
After obtaining the approval from the local institutional review
board, this prospective case–control study was carried out between
April 2013 and June 2014. According to the previous published
studies [11–17] with an expected 16% difference in the frequency
of Y-chromosome microdeletion with a power of 80% and a 5%
level of significance, 44 men were calculated for each group. After
adding 10% of expected dropout, our study required a total of
97 men. It included 50 men with primary infertility diagnosed
as azoospermia or severe oligozoospermia (study group) and 54
healthy normal fertile men (control group). Each patient agreeing
to participate in the study provided a written informed consent prior
to enrollment. Basic infertility evaluation included a detailed med-
ical history and physical examination, semen analysis, hormonal
assessment (serum FSH, LH, testosterone and prolactin) and scro-
tal color Doppler ultrasonography. Also, the patients’ partners were
examined by gynecologists to ensure normal results from the gyne-
cological point of view before including the male patients in the
study. Patients with secondary infertility, genital anomalies, scrotal
varicocele, genital infection, and those with hormonal defects or
seminal tract obstruction were excluded.
Age-matched control subjects were recruited from normal fertile
men who presented to the urology outpatient clinics due to different
complaints. They were subjected to thorough history taking, clinical
examination and semen analysis, and only men with normal semen
parameters who had fathered at least one child without assisted
reproductive technologies were included.
Study  procedures
Semen  analysis
In all participants, semen analysis was performed at least twice at
one-month intervals, following 3 days of sexual abstinence. The
semen samples were collected and examined after 10 min of cen-
trifugation at 800 ×  g. The mean values of different semen analysis
results were reported and used as average results. The reference
values set by the World Health Organization (WHO) in 2010 [18]
were used: a sperm count over 15 million sperms/mL was consid-
ered normal, while a sperm count ≤5 million/mL was defined as
oligozoospermia and the absence of sperms as azoospermia.
DNA  analysis  by  PCR
Blood and semen samples were taken from all participants for
DNA analysis. The DNA was extracted using DNA extraction kits
(Genorise,USA). Then DNA amplification by multiplex PCR was
performed using STS primers for the AZFa sub-region (sY81, sY84
and sY86), the AZFb sub-region (sY127, sY134 and RBM1), the
AZFc sub-region (sY254, sY255 and CDY) and the SRY gene
(sY14). Samples showing microdeletions on the first screening were
verified by subsequent multiplex PCR amplification for another two
times, and the deleted loci were confirmed by simplex PCR. The
complete description of primers used for detecting Y-chromosome
microdeletion and the amplification sets are shown in Table 1. The
multiplex PCR amplification condition was optimized as follows:
initial denaturation in 94 ◦C for 5 min, followed by 32 cycles of 94 ◦C
for 30 s, 57 ◦C for 30 s and 72 ◦C for 90 s; with a final extension at
72 ◦C for 7 min.
Analysis  and  visualization
The PCR products were separated by electrophoresis on a 2%
agarose gel stained with ethidium bromide. They were then viewed
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Table  1  The three STS primer sets used in detecting Y-
chromosome microdeletions.
STS
primers
Sequences
SRY gene
on (Yp)
sY14 5′-GAATATTCCCGCTCTCCGGA-3′
5′-GCTGGTGCTCCATTCTTGAG-3′
sY81 5′-AGG CAC TGG TCA GAA TGA AG-3′
5′-AAT GGA AAA TAC AGC TCC CC-3′
AZFa sY84 5′-AGA AGG GTC TGA AAG CAG GT-3′
5′-GCC TAC CTG GAG GAG GCT TC-3
sY86 5′-GTG ACA CAC AGA CTA TGC TTC-3′
5′-ACA CAC AGA GGG ACA ACC CT-3′
RBM1 5′-ATG CAC TTC AGA GAT ACG G-3′
5′-CCT CTC TCC ACA AAA CCA ACA-3′
AZFb sY127 5′-GGC TCA CAA ACG AAA AGA AA-3′
5′-CTG CAG GCA GTA ATA AGG GA-3′
sY134 5′-GTC TGC CTC ACC ATA AAA CG-3′
5′-CCG TGT GCT GGA GAC TAA TC-3′
CDY 5′-TCA TAC AAT CCA ATT GTA CTG G-3′
5′-TTC TAT CCC TCG GGC TGA GCT C-3′
AZFc sY254 5′-GGG TGT TAC CAG AAG GCA AA-3′
5′-GAC CGT ATC TAC CAA AGC TGC-3′
sY255 5′-GTT ACA GGA TTC GGC GTG AT-3′
5′-CTC GTC ATG TGC AGC CAC-3′
under UV trans-illumination. Negative controls with a DNA tem-
plate were included with each reaction. Photographs of the gel were
taken using a gel documentation system.
Testicular  biopsy
In an open procedure and under general anesthesia unilateral tes-
ticular biopsies were taken from some infertile men. All tissue
biopsies were fixed in Bouin’s solution, processed, imbedded in
paraffin, sectioned, stained with Hematoxylin and Eosin, and then
examined for histological anomalies.
Data  analysis
The data was presented as median and range or number and percent-
age. Fisher exact test was used for comparison and values of <0.05
were considered statistically significant.
Results
In total, 50 infertile men were studied; 34 (68%) of them had
azoospermia and 16 (32%) severe oligozoospermia. The patients’
age ranged from 23 to 52 years (median: 30 years) and the duration
of infertility ranged from 1 to 22 years (median: 3 years). Addition-
ally, 54 normal fertile men aged between 22 and 46 years (median:
29 years) were studied as controls.
Sixteen microdeletions were found in the DNA extracted from
blood, while 19 microdeletions were found in the DNA extracted
from semen, whereas no deletion was detected in the control group.
Microdeletions were detected in the 3 AZFb loci in one case, in both
AZFb and AZFc loci in another and in two AZFc loci (sY254 and
sY255) in a third case; 8 cases (72.7%) had sporadic microdeletions
in a single locus: sY84 (2 cases), sY86 (one case), sY134 (2 cases),
sY254 (2 cases), and sY255 (one case). On the other hand, SYR
gene screening was normal in all infertile patients and the control
Fig.  1  Gel photograph (STS primers for sY84, sY127 and sY254)
showing microdeletion of sY254 in lane (3) and microdeletion of sY127
in lane (5) in DNA blood samples.
Fig.  2  Gel photograph showing deletions of the sY84 loci in both
DNA from blood (A) and semen (B) in case number 5 (arrows), while
deletion of the same locus was detected only in DNA from semen in
case number 10 (triangles).
group. Moreover, the incidence of both AZFb and AZFc microdele-
tions was 14% (DNA from blood) and 16% (DNA from semen),
whereas AZFa microdeletions were found in only 2% (DNA from
blood) and 4% (DNA from semen) of the patients. The differences
between the frequency of the deletions detected in DNA from blood
and DNA from semen were statistically non-significant in all cases.
Tables 2 and 3 illustrate the distribution and the percentage of all
deletions detected associated with semen analysis and the possi-
ble testicular changes. Fig. 1 shows a multiplex PCR indicating
microdeletions of sY254 in lane 3 and of sY127 in lane 5 in DNA
from blood samples. Fig. 2 shows a simplex PCR for one of the
AZFa sub-regions (sY84) in DNA from blood and semen; the dele-
tion was detected in one locus in DNA from blood and in two loci
in DNA from semen.
Testicular biopsies revealed variable testicular changes such as a
mixed pattern of atrophic and hyalinized seminiferous tubules with
some scattered small tubules containing Sertoli cells only, with com-
plete or partial loss of spermatogenic cells (Fig. 3A and B); Sertoli
cells only with germ cell aplasia (Fig. 4); immature germ cells,
including several spermatocytes, and arrested spermatogenesis at a
spermatid stage; i,e. complete absence of spermatozoa (Fig. 5).
Discussion
Y-chromosome microdeletion in azoospermia factor (AZF) loci
is a common genetic cause of male infertility. Y-chromosome
microdeletions are frequently diagnosed in a variable percentage
of infertile men world-wide [19]. The frequency of Y-chromosome
microdeletions in our 50 azoospermic/severely oligozoospermic
infertile men was 22% (11/50). Also, the incidence of AZF
microdeletions showed no variation between DNA from blood and
semen (Table 3).
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Table  2  The frequency and distribution of all microdeletions detected associated with semen analysis and testicular histological changes.
Semen analysis Testicular biopsy AZFa AZFb AZFc
sY81 sY84 sY86 sY127 RBM1 sY134 SDY sY254 sY255
Case 1 Azoospermia Hyalinized seminiferous tubules, with others
contain Sertoli cells only (Fig. 3A)
Bl. DNA +
Se. DNA +
Case 2 Sever oligozoospermia Not available Bl. DNA +
Se. DNA +
Case 3 Azoospermia Seminiferous tubules filled with
disorganized sloughing germ cells (Fig. 5B)
Bl. DNA +  + + + + +
Se. DNA +  + + + + +
Case 4 Azoospermia Not available Bl. DNA +
Se. DNA +
Case 5 Azoospermia Sertoli cells only (Fig. 3B) Bl. DNA +
Se. DNA +
Case 6 Azoospermia Seminiferous tubules filled with
disorganized sloughing germ cells (Fig. 5A)
Bl. DNA + +
Se. DNA +  +
Case 7 Azoospermia Sertoli cells only (Fig. 4) Bl. DNA + + +
Se. DNA +  + +
Case 8 Sever oligozoospermia Not available Bl. DNA −
Se. DNA +
Case 9 Sever oligozoospermia Seminiferous tubules filled with
disorganized sloughing germ cells
Bl. DNA −
Se. DNA +
Case 10 Azoospermia Sertoli cells only (Fig. 3B) Bl. DNA −
Se. DNA +
Case 11 Sever oligozoospermia Not available Bl. DNA +
Se. DNA +
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Table  3  The number and percentage of each single STS locus deleted.
STS primers Blood DNA(n = 50) Semen DNA(n = 50) P-value
AZFa
sY 81 0 0
sY84 1 (2%) 2 (4%)
sY86 1 (2%) 1 (2%)
Total 2 (4%) 3 (6%) 0.500
AZFb
sY127 2 (4%) 2 (4%)
RBM1 2 (4%) 2 (4%)
sY134 3 (6%) 4 (8%)
Total 7 (14%) 8 (16%) 0.500
AZFc
CDY 1 (2%) 1 (2%)
sY254 4 (8%) 4 (8%)
sY255 2 (4%) 3 (6%)
Total 7 (14%) 8 (16%) 0.500
Fig.  3  Photo-histogram from a testicular biopsy showing hyalinized seminiferous tubules with thickened basement membranes; some are occluded
with complete absence of spermatogenic cells (white head arrows), and others contain Sertoli cells with complete or partial loss of spermatogenic
cells (yellow arrows) [Hematoxylin and Eosin stain A = ×200; B = ×400].
Our study results differ significantly from other studies that were
carried out on azoospermic/severely oligozoospermic patients. The
frequency of Y-chromosome microdeletions found in our study is
much higher than that reported by some investigators. For example,
Behulova et al. [11] reported a frequency of 3.35% in 226 patients,
Mitra et al. [12] reported a frequency of 5.29% in 170 patients and
Chiang et al. [13] reported a frequency of 8.3% in 218 patients. On
the other hand, the frequency of microdeletions found in our study
Fig.  4  Photo-histogram from a testicular biopsy showing the seminiferous tubules lined with Sertoli cells only with abundant interstitial Leydig
cells. [Hematoxylin and Eosin stain. ×400.]
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Fig.  5  Photo-histogram from a testicular biopsy showing seminiferous tubules filled with disorganized sloughing germ cells (A), or incomplete
spermatogenesis (B). Also, some cells with condensed nuclei are seen in tubules, which may represent apoptotic germ cells or early spermatids.
[Hematoxylin and Eosin stain. ×400.]
is much lower than that reported by others. It was 52% in 50 patients
evaluated by Malekasgar et al. [14], 36% in 75 patients as reported
by Suganthi et al. [15], 24.2% in 99 patients evaluated by Omrani
et al. [16] and 28.4% in 162 patients in the study of Al-Achkar
et al. [17]. The heterogeneity of the results may be due to different
numbers of STS primers used in mutation detection, a variation of
the selective criteria used for infertile patients recruited or the fact
that the studies were conducted on different ethnical populations.
The general frequency of microdeletions with respect to the AZF
sub-regions has been reported to be 60% for AZFc, 16% for AZFb
and 14% for AZFb + c, with great variations between different popu-
lations worldwide [20]. In fact, our results and others lie within these
variations.
The distribution of sporadic AZF microdeletions in our study
showed an increased frequency of deleted AZFa and AZFc loci
[27.3% (3/11) each], followed by deleted AZFb loci [18% (2/11)],
which is nearly similar to the findings of Sheikhha et al. [21]. On
the other hand, other studies [16,22,23] reported a higher frequency
of AZFc microdeletion.
Although many studies have been conducted so far, there are still
heterogeneous and conflicting data on the testicular histological
morphology and its correlation with the deleted AZF loci. Peterlin
et al. [24] reported a marked variability with a poor correlation of
testicular histology with the deleted AZF loci, while others [25,26]
suggested that deletion of a particular AZF sub-region was usually
correlated with specific testicular histological changes.
In the present study, a mixed pattern of hyalinized seminiferous
tubules associated with some tubules containing Sertoli cells only,
with complete absence of spermatogenic cells (Fig. 3), was detected
in testicular biopsies from patients with deleted AZFb + c. Sim-
ilarly, Brisset et al. [27] in their study had noticed atrophic and
hyalinized seminiferous tubules with some sperms in the wet prepa-
ration in cases of unbalanced chromosome Y-22 translocation with
large deletion of the AZF region involving AZFb, AZFc and the
heterochromatic region of the long arm of the Y-chromosome. Other
investigators [10,28] reported an association between the large dele-
tion of Y-chromosome AZFb + c and the lack of sperms in testicular
biopsies.
Several studies [27,29] indicated that the testicular histology of
patients with complete AZFa and/or AZFb microdeletion is usually
associated with Sertoli cells only, while those with partial AZFa and
AZFb or those with AZFc microdeletions show a broad variation of
testicular morphology ranging from Sertoli cells only or spermato-
genetic arrest to hypospermatogenesis with sperms in the ejaculate.
In our study, we detected three cases with AZFa (single locus; sY84,
sY86), two cases with AZFb (single locus; sY143) and one case with
AZFb (the three loci) microdeletion. Testicular biopsies from these
patients show a picture similar to the Sertoli-cell-only syndrome
(Fig. 4) with complete absence of spermatogenic cells. Luetjens et al.
[30] reported in their study that a testis with AZFa microdeletion
showed the picture of a Sertoli-cell-only syndrome, which complies
with our results, whereas AZFb microdeletion shows spermatogenic
arrest at the level of the spermatocytes.
Genes in AZFa (DDX3Y) and in AZFb (KDM5D, RBMY1A1)
seem to be essential for spermatogenic cell development and mat-
uration [31]. So, deletion of AZFa or AZFb is usually associated
with severe testicular damage. We detected three cases with a single
locus deleted from the AZFc sub-region (sY254 or sY255) and one
case with both loci deleted from the AZFc sub-region. Testicular
biopsies from these patients show different patterns of spermato-
genic cell maturation; some tubules contain disorganized germ cells
with sloughing (Fig. 5A), and others have an incomplete or arrested
spermatogenesis (Fig. 5B). This result has been found by numerous
other investigators [27,30,32].
The AZFc sub-region contains several important genes for male
infertility: DAZ, BPY2, CDY1 genes that control spermatogenesis
[31,33]. Therefore, the pathological changes associated with AZFc
microdeletion are less severe than those associated with AZFa or
AZFb and show variable changes according to the deleted gene/s.
Additionally, other studies indicated an association between these
chromosomal anomalies and Y-chromosome microdeletions. How-
ever, several cases with chromosomal rearrangements and with
Klinefelter syndrome show AZF deletions [34,35].
Spermatogenesis is regulated by a number of genes on the Y-
chromosome, X-chromosome and autosomes that act at different
stages of germ-cell differentiation and maturation. Several stud-
ies have demonstrated the relationship between balanced autosomal
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translocation and severe oligozoospermia/azoospermia, as well as
sex chromosome anomalies like Klinefelter syndrome and male
infertility [36]. Other studies implied an association between these
chromosomal anomalies and Y-chromosome microdeletions. How-
ever, several cases with chromosomal rearrangements and with
Klinefelter syndrome show AZF deletions [33,34]. The main limi-
tation of our study is the absence of a chromosomal analysis. Future
studies should simultaneously use other measures such as semen
parameters, hormonal assessments, cytogenetics, molecular genet-
ics and testicular histology in patients with AZF deletions and severe
oligozoospermia/azoospermia to assess and improve the outcome of
assisted reproductive techniques.
Conclusions
The frequency of Y-chromosome microdeletions in infertile males
is significantly variable and is associated with variable testicular
pathologies. Routine cytogenetic, molecular investigation of AZF
loci and testicular biopsy are valuable measures in evaluating
infertile men, especially those prepared to benefit from assisted
reproductive technology.
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